Spark Therapeutics
Philadelphia, US · Founded 2013 · 1 known investors
One-time gene therapy products including a candidate for RPE65-related blindness. (NASDAQ: ONCE) (Acquired by Roche)
Founders & leadership
JW
Joseph W. La BargeNamed on SEC filing
ES
Elliott SigalNamed on SEC filing
RV
Rogerio VivaldiNamed on SEC filing
AD
Arthur DantchikNamed on SEC filing
LE
Lars Ekman, M.D. Ph.D.Named on SEC filing
SM
Steven M. AltschulerNamed on SEC filing
JD
Jeffrey D. MarrazzoNamed on SEC filing
AM
Anand MehraNamed on SEC filing
Investors · 1
Reported raises · per SEC filings
Form D private placements$72.8M disclosed across 1 round · 2014
▶$72.8MraisedJun 2014 · 28 investors · BiotechnologyRule 506(b)
▶$72.8MraisedJun 2014 · 28 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Joseph W. La BargeExecutive Officer
- Elliott SigalDirector
- Rogerio VivaldiDirector
- Arthur DantchikDirector
- Lars Ekman, M.D. Ph.D.Director
- Steven M. AltschulerDirector
- Jeffrey D. MarrazzoExecutive Officer, Director
- Anand MehraDirector
- Offering amount
- $72.8M
- Amount sold
- $72.8M
- First sale
- May 2014
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Spark Therapeutics do?
- One-time gene therapy products including a candidate for RPE65-related blindness. (NASDAQ: ONCE) (Acquired by Roche)
- Who are Spark Therapeutics's investors?
- Spark Therapeutics's investors include Sofinnova Ventures.
- How much funding has Spark Therapeutics raised?
- Spark Therapeutics has disclosed $72.8M raised across 1 round.
- Where is Spark Therapeutics headquartered?
- Spark Therapeutics is headquartered in Philadelphia, US.